Cyclobenzaprine

Common Uses

Cyclobenzaprine is primarily used to treat muscle spasms associated with sudden, painful musculoskeletal conditions. It is typically prescribed to help relieve symptoms such as:

• Muscle pain
• Stiffness
• Discomfort caused by strains or sprains

This medication is intended for short-term use, usually for a period of two to three weeks. It is meant to be used as part of a comprehensive treatment plan that includes:

• Rest
• Physical therapy
• Other measures recommended by a healthcare provider

Cyclobenzaprine works by helping to relax the muscles, which can improve mobility and reduce pain during the recovery process from an injury. It is not generally used for muscle spasms caused by chronic neurological conditions, such as cerebral palsy or spinal cord disease.

Mechanism of Action

Cyclobenzaprine belongs to a class of medications known as skeletal muscle relaxants. It does not work directly on the muscles themselves; instead, it acts on the central nervous system, which includes the brain and spinal cord.

The medication helps relieve muscle symptoms through the following processes:

• Interrupting Nerve Signals: It works by blocking nerve impulses or pain sensations that travel from the affected muscles to the brain.
• Reducing Muscle Spasms: By acting on the brain stem, it helps decrease the frequency and intensity of muscle contractions.

This action helps to relieve the pain, stiffness, and discomfort caused by muscle strains, sprains, or other injuries. It is typically used for short periods as part of a treatment plan that includes rest and physical therapy.

Common Side Effects

The most frequently reported side effects of cyclobenzaprine include:

• Drowsiness or fatigue
• Dizziness
• Dry mouth
• Headache
• Constipation
• Nausea, heartburn, or stomach pain
• Blurred vision
• Nervousness

Serious Side Effects

Contact a healthcare provider immediately or seek emergency medical care if you experience any of the following:

• Signs of an allergic reaction, such as skin rash, hives, or swelling of the face, lips, tongue, or throat
• Chest pain or pressure
• Rapid, pounding, or irregular heartbeat
• Difficulty breathing or swallowing
• Severe dizziness or fainting
• Confusion or hallucinations
• Yellowing of the skin or eyes
• Unusual bruising or bleeding

Cyclobenzaprine may cause a serious condition called serotonin syndrome, especially when taken with certain other medications. Symptoms include agitation, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.

Heart and Thyroid Conditions

Cyclobenzaprine is contraindicated for use in individuals with certain cardiovascular conditions. This includes those who have recently experienced a heart attack, or those with heart rhythm disorders, heart block, or congestive heart failure. It is also not recommended for people with hyperthyroidism.

Serious Drug Interactions

MAO Inhibitors: Cyclobenzaprine must not be used by individuals currently taking monoamine oxidase (MAO) inhibitors or those who have taken them within the last 14 days. Combining these medications can result in severe seizures or death.

Serotonin Syndrome: A serious condition called serotonin syndrome may occur when cyclobenzaprine is used with other drugs that increase serotonin levels, such as SSRIs, SNRIs, or tricyclic antidepressants. Symptoms can include confusion, rapid heartbeat, sweating, and muscle tremors.

CNS Depressants: Using cyclobenzaprine alongside alcohol, benzodiazepines, or opioids can lead to extreme sedation and may increase the risk of respiratory depression.

General Precautions

• Mental Alertness: This medication often causes drowsiness and dizziness. Activities requiring mental alertness, such as driving or operating machinery, may be unsafe while using this drug.
• Anticholinergic Effects: Due to its chemical structure, cyclobenzaprine can cause dry mouth, blurred vision, and urinary retention. Caution is advised for individuals with a history of glaucoma or difficulty urinating.
• Liver Function: Use is generally avoided or limited in individuals with moderate to severe liver impairment.
• Elderly Use: Older adults may experience increased side effects, such as confusion or hallucinations, and are at a higher risk for falls while taking this medication.

Pregnancy

It is not known whether cyclobenzaprine can harm an unborn baby. While animal studies have not shown evidence of birth defects or other developmental issues, there are no well-controlled studies in pregnant women. Because human data is limited, healthcare providers typically only prescribe this medication during pregnancy if the potential benefit outweighs the potential risk.

If you are pregnant or planning to become pregnant, you should discuss the risks and benefits of using cyclobenzaprine with your doctor before starting or continuing the medication.

Breastfeeding

It is currently unknown if cyclobenzaprine passes into human breast milk. Many medications do pass into breast milk in small amounts, and there is a possibility that it could cause side effects in a nursing infant. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to determine the safest course of action for you and your baby.

Oral Tablet

Cyclobenzaprine is available as an immediate-release tablet. This form is typically taken multiple times a day as directed by a healthcare provider.

Oral Extended-Release Capsule

This medication also comes in an extended-release capsule form. Extended-release capsules are designed to release the medication slowly into the system over a longer period and are generally taken once daily.

FDA Approval and Indications

Cyclobenzaprine was first approved by the U.S. Food and Drug Administration (FDA) in 1977. It is indicated for use alongside rest and physical therapy to relieve muscle spasms associated with acute, painful musculoskeletal conditions. The FDA recommends that use be limited to short periods, typically two to three weeks, because there is limited evidence of effectiveness for longer-term treatment.

Safety Communications and Warnings

The FDA has issued safety communications regarding the risks of combining muscle relaxants like cyclobenzaprine with opioid pain medications or benzodiazepines. This combination can lead to extreme sleepiness, respiratory depression, coma, and death. Healthcare providers are advised to limit co-prescribing these medications to cases where alternative treatment options are inadequate.

In 2017, the FDA identified a potential signal of serious risk for serotonin syndrome associated with cyclobenzaprine. This condition can occur when cyclobenzaprine is taken with other drugs that affect serotonin levels, such as certain antidepressants (SSRIs, SNRIs) or migraine medications (triptans). Symptoms of serotonin syndrome can include agitation, hallucinations, rapid heart rate, and muscle stiffness.

Regulatory Classification

Cyclobenzaprine is available only by prescription. It is not currently classified as a controlled substance under the federal Controlled Substances Act.

Withdrawal Symptoms

Cyclobenzaprine is typically prescribed for short-term use, usually for periods of two to three weeks. If the medication is taken for a longer duration or in high doses, stopping it abruptly may lead to withdrawal symptoms.

Commonly reported withdrawal symptoms include:

• Nausea
• Headache
• Malaise (a general feeling of discomfort or illness)

These symptoms are generally not life-threatening, but they can be unpleasant. Because of the risk of withdrawal, healthcare providers usually recommend gradually tapering the dose rather than stopping the medication all at once. It is important to consult with a healthcare professional before making changes to how you take this medication.